Cyclooxygenase‐2 and gastric carcinogenesis (Q28184447)

title

Cyclooxygenase-2 and gastric carcinogenesis (English)

0 references

Cyclooxygenase‐2 and gastric carcinogenesis (English)

1 reference

https://api.crossref.org/works/10.1034/J.1600-0463.2003.1111001.X

1 April 2024

1 reference

Kirsi Saukkonen

1

0 references

Johanna Rintahaka

2

0 references

Anna Sivula

3

0 references

Marie-Christine Rio

6

0 references

Caj Haglund

7

0 references

Ari Ristimaki

10

0 references

Christianne J. Buskens

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616542

1 April 2024

Bastiaan P. Van Rees

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616542

1 April 2024

J. Jan B. Van Lanschot

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616542

1 April 2024

G. Johan A. Offerhaus

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616542

full work available at URL

1 April 2024

language of work or name

English

0 references

publication date

October 2003

0 references

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1034%2Fj.1600-0463.2003.1111001.x

1 reference

https://api.crossref.org/works/10.1034/J.1600-0463.2003.1111001.X

https://onlinelibrary.wiley.com/doi/pdf/10.1034/j.1600-0463.2003.1111001.x

1 April 2024

1 reference

https://api.crossref.org/works/10.1034/J.1600-0463.2003.1111001.X

Acta Pathologica et Microbiologica Scandinavica

1 April 2024

published in

0 references

volume

111

0 references

page(s)

915-25

0 references

issue

10

0 references

cites work

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

1 reference

https://api.crossref.org/works/10.1034/J.1600-0463.2003.1111001.X

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

21 April 2017

1 reference

https://api.crossref.org/works/10.1034/J.1600-0463.2003.1111001.X

Aspirin and risk for gastric cancer: a population-based case-control study in Sweden

21 April 2017

1 reference

https://api.crossref.org/works/10.1034/J.1600-0463.2003.1111001.X

Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein

21 April 2017

1 reference

https://api.crossref.org/works/10.1034/J.1600-0463.2003.1111001.X

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1034/J.1600-0463.2003.1111001.X

Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice

21 April 2017

1 reference

https://api.crossref.org/works/10.1034/J.1600-0463.2003.1111001.X

21 April 2017

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

21 April 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.

21 April 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

The relationship between cyclooxygenase-2 expression and colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

Molecular epidemiology, pathogenesis and prevention of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

Aspirin protects against gastric cancer: results of a case-control study from Moscow, Russia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

Expression of COX-2 in stomach cancers and its relation to their biological features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

Expression of cyclooxygenase-2 and clinicopathologic features in human gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

Overexpression of cyclooxygenase-2 protein is less frequent in gastric cancers with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

Association of cyclooxygenase-2 expression with Hp-cagA infection in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

Clinicopathologic association of cyclooxygenase 1 and cyclooxygenase 2 expression in gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

Cyclooxygenase-2 expression is associated with well-differentiated and intestinal-type pathways in gastric carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

Expression of cyclooxygenase-2 in primary and remnant gastric carcinoma: comparing it with p53 accumulation, Helicobacter pylori infection, and vascular endothelial growth factor expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

Cyclooxygenase-2 expression during carcinogenesis in the human stomach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

Inhibition of cyclooxygenase-2 gene expression by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

Paracrine cyclooxygenase-2-mediated signalling by macrophages promotes tumorigenic progression of intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

Cyclooxygenase-2 inhibitors in tumorigenesis (part I)

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

7 January 2021

Cyclooxygenase-2 inhibitors in tumorigenesis (Part II)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

7 January 2021

The role of cyclooxygenase inhibitors in cancer prevention

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

7 January 2021

Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

7 January 2021

The two histological main types of gastric carcinoma: diffuse and so called intestinal-type carcinoma: an attempt at a histo-clinical classification

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

7 January 2021

Aspirin use and lung, colon, and breast cancer incidence in a prospective study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

7 January 2021

Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

7 January 2021

Expression of cyclooxygenase-2 in human gastric adenomas and adenocarcinomas

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

7 January 2021

Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

7 January 2021

Cytosolic phospholipase A2, cyclo-oxygenases and arachidonate in human stomach tumours

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

7 January 2021

Inverse association between cyclooxygenase-2 overexpression and microsatellite instability in gastric cancer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

7 January 2021

Expression of nitric oxide synthase, cyclooxygenase, and p53 in different stages of human gastric cancer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

7 January 2021

Cyclooxygenase-2 expression is increased in early intestinal-type gastric cancer and gastric mucosa with intestinal metaplasia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

7 January 2021

Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

7 January 2021

Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10(-/-) mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

7 January 2021

Effects of NSAIDs on NNK-induced pulmonary and gastric tumorigenesis in A/J mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

7 January 2021

Combinatorial chemoprevention of intestinal neoplasia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

7 January 2021

Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.1111001.X

7 January 2021

Aspirin use and risk of fatal cancer

29

1 reference

https://api.crossref.org/works/10.1034/J.1600-0463.2003.1111001.X

Expression of cyclooxygenase-2 protein in gastric adenocarcinoma.

1 April 2024

41

1 reference

https://api.crossref.org/works/10.1034/J.1600-0463.2003.1111001.X

Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma

1 April 2024

43

1 reference

https://api.crossref.org/works/10.1034/J.1600-0463.2003.1111001.X

Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice

1 April 2024

71

1 reference

https://api.crossref.org/works/10.1034/J.1600-0463.2003.1111001.X

Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo

1 April 2024

72

1 reference

https://api.crossref.org/works/10.1034/J.1600-0463.2003.1111001.X

1 April 2024

Identifiers

1 reference

Consolidated OpenCitations Corpus – April 2017

289295

289295

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference